Reportlinker Adds Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth

Jun 07, 2010, 13:50 ET from Reportlinker

NEW YORK, June 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth

http://www.reportlinker.com/p0203701/Business-Intelligence-in-the-Pharmaceutical-Market-Growth-drivers-key-organizational-priorities-and-vendor-strategies-for-future-growth.html

The pharmaceutical industry is challenged with information integration and mapping across the various business processes. This information challenge, along with other issues such as weak product development pipelines, growing generics competition, and rising R&D and regulatory compliance costs are compelling pharmaceutical companies to look for alternatives to remain competitive, maintain profit margins, and enhance market share. Implementation of Business Intelligence (BI) enables the business processes to access more accurate and real-time information, with an ultimate goal of increased efficiency and reduced corporate costs.

This report provides an overview of the BI market in the pharmaceutical sector, including its size and growth, followed by the current trends of BI technologies and adoption of BI tools across key pharmaceutical processes. It gives an insight into the various key players in the BI market, analyzing them based on their product offerings and growth strategies. In addition to the BI supply side, this report assesses the state of the BI market from the demand side perspective. Demand side analysis investigates the uptake of BI in the pharmaceutical sector, investments in current BI use, and planned future use.

Key features of this report

  • Analysis of the BI market in the pharmaceutical sector in terms of size and growth rate.
  • Evaluation of the drivers behind the increased spending on BI solutions by Big Pharma companies.
  • Key challenges in developing a data warehouse that delivers BI capabilities for the pharmaceutical industry.
  • Demand side analysis of the uptake of BI in the pharmaceutical sector, investment in current BI use, and planned future use.
  • Insight into the activities, views, and strategies of the major BI vendors.

Scope of this report

  • Understand the BI needs across major pharmaceutical industry processes and the benefits that entail from BI implementation.
  • Understand the uptake of BI in the pharmaceutical sector by organization size and by geographic location.
  • Identify the organizational priorities of life science companies and how BI can improve the quality of decision making.
  • Benchmark your performance against the major BI vendors based on knowledge of their product offerings and growth strategies.

Key Market Issues

  • The data intensive nature of the pharmaceutical industry makes BI deployment more challenging than other industries.
  • Data availability at different time periods, frequent changes in the legislation, and growing consolidation in the pharmaceutical industry makes the BI adoption process particularly challenging.
  • Reduction of knowledge process service costs is a pressing priority for most pharmaceutical companies.
  • BI vendors need to work with the pharmaceutical companies to identify areas or patterns where the costs can be reduced and educate the pharmaceutical companies about the advantages of moving towards adopting easy to use and prepackaged pharma-specific BI solutions.

Key findings from this report

  • The BI market in the pharmaceutical industry was worth around $495m in 2009, and is forecast to grow to $555m by 2012.
  • Besides achieving operational excellence, pharmaceutical companies are investing in BI implementation in technical areas, such as to improving research and clinical performance, resource management, sales force tracking and regulatory compliance reporting.
  • Business Insights' survey of the pharmaceutical sector found that 67% of the respondents currently use BI tools.
  • Of current users, 71% have indicated that launching new products and services in existing markets is likely to influence their decision over whether to increasingly use BI tools and services in 2010–11.
  • Approximately 49% of respondents confirmed their intention to reduce SG&A costs in 2010–11.

Key questions answered

  • What is the market size and growth rate over the period 2006-2012 for BI spending in pharmaceutical sector?
  • What are the major drivers for increased BI adoption in the pharmaceutical sector?
  • What are the key challenges that make BI adoption difficult for the industry?
  • What does the current BI vendor landscape look like?
  • How will the emerging advanced analytics capabilities and industry/process-specific offerings determine which vendors remain dominant in the future?

Table of Contents

Business Intelligence in the Pharmaceutical Market

Executive summary 10

The Business Intelligence market in the pharmaceutical sector 10

Key processes in the pharmaceutical sector 10

The uptake of Business Intelligence in the pharmaceutical sector 11

The demand side of Business Intelligence in the pharmaceutical sector 12

The Business Intelligence vendor landscape 12

The future of the Business Intelligence market in the pharmaceutical sector 13

Chapter 1 Introduction 16

Introduction 16

Who is this report for? 17

Research methodology 17

Chapter 2 The Business Intelligence market in the pharmaceutical sector 20

Summary 20

Introduction 21

Importance of BI in the pharmaceutical industry 21

BI market in the pharmaceutical industry: size and growth 22

Drivers for BI adoption in the pharmaceutical industry 24

Enabling strategic decision making 25

Enabling identification of latest sales forecasts and trends 25

Increased outsourcing 26

Attaining cost efficiency 26

Challenges for implementing BI in the pharmaceutical industry 26

Current BI trends in the pharmaceutical industry 27

BI moving beyond operational excellence to technical areas 29

Customized service offering by BI vendors 29

Chapter 3 Key processes in the pharmaceutical sector 32

Summary 32

Introduction 32

Pharmaceutical processes 33

Drug discovery 34

Drug development 34

Manufacturing and supply chain 35

Sales and marketing 36

Chapter 4 The uptake of Business Intelligence in the pharmaceutical sector 40

Summary 40

Introduction 40

Business Intelligence uptake 41

Current BI usage 41

Uptake by organization size 42

Uptake by geographies 43

Short-term BI drivers among current users 44

Longer-term BI drivers among current users 45

BI usage forecast 46

BI usage forecast by components 47

BI usage forecast by enterprise functions 47

Planned increases in spending on Business Intelligence 48

Plans to increase usage: case for persuasion 50

Chapter 5 The demand side of Business Intelligence in the pharmaceutical sector 52

Summary 52

Introduction 52

Organizational priorities 52

Cost reduction: which areas to target? 54

Reducing SG&A costs 54

Cost reduction priorities 55

Business Intelligence users – case studies 56

GlaxoSmithKline – management of the clinical trial process and enhancement of drug development 57

Wyeth Pharma – managing sales effectiveness 57

Chapter 6 The Business Intelligence vendor landscape 60

Summary 60

Introduction 61

The mega vendors 62

IBM Business Intelligence: Cognos, SPSS, ILOG, and IBM BAO 63

Company overview 63

Key offerings and verticals 63

Pharmaceutical solutions and major customers 64

Competitors 64

Growth strategies 65

Microsoft Business Intelligence 66

Company overview 66

Key offerings and verticals 67

Pharmaceutical solutions and major customers 68

Competitors 68

Growth strategies 69

Oracle 70

Company overview 70

Key offerings and verticals 70

Pharmaceutical solutions and major customers 71

Competitors 72

Growth strategies 72

SAP BusinessObjects 73

Company overview 73

Key offerings and verticals 73

Pharmaceutical solutions and major customers 75

Competitors 75

Growth strategies 76

Niche vendors 77

Actuate 77

Company overview 77

Key offerings and verticals 78

Pharmaceutical solutions and major customers 78

Competitors 79

Growth strategies 79

Information Builders 80

Company overview 80

Key offerings and verticals 80

Pharmaceutical solutions and major customers 81

Competitors 82

Growth strategies 82

MicroStrategy 82

Company overview 82

Key offerings and verticals 83

Pharmaceutical solutions and major customers 84

Competitors 85

Growth strategies 85

QlikTech 86

Company overview 86

Key offerings and verticals 86

Pharmaceutical solution and major customers 86

Competitors 86

Growth strategies 87

SAS 88

Company overview 88

Key offerings and verticals 88

Pharmaceutical solutions and major customers 89

Competitors 90

Growth strategies 90

TIBCO Spotfire 91

Company overview 91

Key offerings and verticals 91

Pharmaceutical solutions and major customers 92

Competitors 93

Growth strategies 93

Chapter 7 The future of the Business Intelligence market in the pharmaceutical sector 96

Summary 96

Introduction 97

Transition of the pharmaceutical sales and marketing model through predictive analytics 98

Major vendors 99

Shifting to in-memory analytics helps rapid information delivery to the sales force 100

Major vendors 100

Leveraging SaaS for data analytics 101

Major vendors 101

Open source paving its way into SMBs 102

Major vendors 102

Appendix 105

Glossary 105

Index 107

List of Figures

Figure 2.1: BI spending by big pharma in the US and Europe ($m), 2006–2012 23

Figure 2.2: Drivers and challenges for BI implementation in the pharmaceutical industry 24

Figure 2.3: Current BI trends in the pharmaceutical industry 28

Figure 3.4: Pharma-specific typical Business Intelligence solutions 33

Figure 4.5: BI usage by organizations (% respondents, 2010) 41

Figure 4.6: Current BI users by areas of operation (% respondents using BI, 2010) 42

Figure 4.7: BI users by organization size (% respondents, 2010) 43

Figure 4.8: BI users by geography (% respondents, 2010) 44

Figure 4.9: Short-term factors most likely to drive BI uptake among current users 45

Figure 4.10: Longer-term factors likely to drive BI uptake among current users (% respondents) 46

Figure 4.11: Forecast of BI usage by components (% respondents) 47

Figure 4.12: Forecast of BI usage by enterprise functions (% respondents) 48

Figure 4.13: Current user plans to change spending on BI in 2010–2011 49

Figure 4.14: Case for persuasion: current BI user indecisiveness by enterprise functions 50

Figure 5.15: Organizational priorities 53

Figure 5.16: Is reduction of SG&A costs a high priority in 2010? 55

Figure 5.17: Cost reduction priorities by enterprise function 56

Figure 6.18: Business Intelligence vendor landscape 61

Figure 6.19: Summary of the mega vendors 62

Figure 7.20: Spectrum of Business Intelligence technologies 97

List of Tables

Table 3.1: Drug discovery KPIs and BI solutions 34

Table 3.2: Drug development KPIs and BI solutions 35

Table 3.3: Manufacturing and supply chain KPIs and BI solutions 36

Table 3.4: Sales and marketing KPIs and BI solutions 37

Table 6.5: IBM Cognos Business Intelligence offerings 63

Table 6.6: IBM Cognos pharmaceutical solutions 65

Table 6.7: IBM major M&A deals, 2008–2010* 66

Table 6.8: Microsoft Business Intelligence offerings 67

Table 6.9: Microsoft Business Intelligence pharmaceutical solutions 68

Table 6.10: Microsoft Business Intelligence major M&A deals, 2008–2010* 70

Table 6.11: Oracle Business Intelligence offerings 71

Table 6.12: Oracle pharmaceutical solutions 71

Table 6.13: Oracle major M&A deals, 2008–10* 73

Table 6.14: SAP BusinessObjects Business Intelligence offerings 74

Table 6.15: SAP BusinessObjects pharmaceutical solutions 75

Table 6.16: SAP BusinessObjects major M&A deals, 2008–2010* 77

Table 6.17: Actuate Business Intelligence offerings 78

Table 6.18: Actuate pharmaceutical solutions 79

Table 6.19: Actuate major M&A deal, 2008–2010* 80

Table 6.20: Information Builders' Business Intelligence offerings 81

Table 6.21: Information Builders' pharmaceutical solutions 81

Table 6.22: MicroStrategy Business Intelligence offerings 83

Table 6.23: MicroStrategy pharmaceutical solutions 84

Table 6.24: QlikTech pharmaceutical solutions 87

Table 6.25: SAS Business Intelligence offerings 88

Table 6.26: SAS pharmaceutical solutions 89

Table 6.27: SAS major M&A deals, 2008–2010* 91

Table 6.28: TIBCO Spotfire Business Intelligence offerings 92

Table 6.29: TIBCO Spotfire pharmaceutical solutions 92

Table 6.30: TIBCO Spotfire major M&A deal, 2008–2010* 94

To order this report:

Pharmaceutical Industry: Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626



SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com